Immune-Mediated Glycocalyx Remodeling in Hospitalized COVID-19 Patients.

Sascha N GoonewardenaOlga G GrushkoJoanna WellsLauren HertyRobert S RosensonJacob M HausScott L Hummel

Published in: Cardiovascular drugs and therapy (2021)

We propose that GAC markers offer insights into the pathobiology of COVID-19, potentially guide therapeutic approaches, and could aid in early risk stratification that is particularly beneficial in phasic diseases such as COVID-19.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus